Mark Gurnell

14.4k citations
161 papers · 5.5k · 1 hit paper · h-index 36

Impact in

  • Endocrinology, Diabetes and Metabolism top 0.5%
    • Thyroid Disorders and Treatments
    • Pituitary Gland Disorders and Treatments
    • Hormonal Regulation and Hypertension
    • Growth Hormone and Insulin-like Growth Factors
  • Physiology top 2%
    • Adipose Tissue and Metabolism

Papers in

  • Endocrinology, Diabetes and Metabolism 97
    • Pituitary Gland Disorders and Treatments 50
    • Thyroid Disorders and Treatments 24
    • Hormonal Regulation and Hypertension 23
    • Growth Hormone and Insulin-like Growth Factors 15
  • Surgery 36
    • Adrenal and Paraganglionic Tumors 26
Co-authors
Krishna Chatterjee (30 shared papers)Maura Agostini (12 shared papers)Stephen O’Rahilly (6 shared papers)John Coates (6 shared papers)John W. R. Schwabe (8 shared papers)Maria A. Soos (2 shared papers)Inês Barroso (1 shared paper)Vivion Crowley (1 shared paper)
Journals
The Journal of Clinical Endocrinology & Metabolism (14 papers)Clinical Endocrinology (10 papers)Pituitary (9 papers)European Journal of Endocrinology (7 papers)Medical Teacher (5 papers)
Partner nations
United KingdomUnited StatesNetherlands

In The Last Decade

Mark Gurnell

152 papers receiving 5.3k citations

Mark Gurnell's Hit Papers

Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension 1999 · 1.1k citations
1.1k0+9+18Years since publication2505007501000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 1999 Nature

Peers

Mark Gurnell
Comparison fields: 5 of 150
  • Endocrinology, Diabetes and Metabolism 2.1k
  • Physiology 1.0k
  • Biochemistry 250
  • Molecular Biology 2.0k
  • General Decision Sciences 46
Replace Richard M. O’Brien with:
Richard M. O’Brien United States
Marina Bianchi Italy
Robert K. Semple United Kingdom
Paul W. Sanders United States
Ivan S. Yuhanna United States
James Scott United States
Giovanni Vitale Italy
Michael W. Yeh United States
David Rubinstein United States
Anthony N. Hollenberg United States
Mark Gurnell relative to Richard M. O’Brien United States Richard M. O’Brien's profile →
Citations per field
00.5×5×10×15.3×
Richard M. O’Brien · 1×
Citations per year

Countries citing papers authored by Mark Gurnell

Since Specialization
Citations

This map shows the geographic impact of Mark Gurnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gurnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gurnell more than expected).

Fields of papers citing papers by Mark Gurnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gurnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gurnell. The network helps show where Mark Gurnell may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Gurnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Gurnell Line = papers co-authored together Mark Gurnell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension
Nature ·Inês Barroso, Mark Gurnell, Vivion Crowley, Maura Agostini, John W. R. Schwabe, Maria A. Soos, G. Maslen, T D M Williams, Huckaby Lewis, Alan J. Schafer, Krishna Chatterjee, Stephen O’Rahilly
Hit paper breakdown →		19991055
2
Human Metabolic Syndrome Resulting From Dominant-Negative Mutations in the Nuclear Receptor Peroxisome Proliferator-Activated Receptor-γ
Diabetes ·David B. Savage, Garry D. Tan, Carlo L. Acerini, Susan A. Jebb, Maura Agostini, Mark Gurnell, Rachel Williams, A. Margot Umpleby, E. Louise Thomas, Jimmy D. Bell, Adrian K. Dixon, Fidelma Dunne, Romina Boiani, Saverio Cinti, Antonio Vidal‐Puig, Fredrik Karpe, Krishna Chatterjee, Stephen O’Rahilly
2003335
3
Second-to-fourth digit ratio predicts success among high-frequency financial traders
Proceedings of the National Academy of Sciences ·John Coates, Mark Gurnell, Aldo Rustichini
2009247
4
A Dominant-negative Peroxisome Proliferator-activated Receptor γ (PPARγ) Mutant Is a Constitutive Repressor and Inhibits PPARγ-mediated Adipogenesis
Journal of Biological Chemistry ·Mark Gurnell, John M. Wentworth, Maura Agostini, Maria Adams, Trevor N. Collingwood, Claudia Provenzano, P Browne, Odelia Rajanayagam, Thomas P. Burris, John W. R. Schwabe, Mitchell A. Lazar, Krishna Chatterjee
2000245
5
Pitfalls in the measurement and interpretation of thyroid function tests
Best Practice & Research Clinical Endocrinology & Metabolism ·Olympia Koulouri, Carla Moran, David Halsall, Krishna Chatterjee, Mark Gurnell
2013168
6
The Metabolic Syndrome: Peroxisome Proliferator-Activated Receptor γ and Its Therapeutic Modulation
The Journal of Clinical Endocrinology & Metabolism ·Mark Gurnell, David B. Savage, Krishna Chatterjee, Stephen O’Rahilly
2003150
7
Evaluation of the Sensitivity and Specificity of 11 C-Metomidate Positron Emission Tomography (PET)-CT for Lateralizing Aldosterone Secretion by Conn's Adenomas
The Journal of Clinical Endocrinology & Metabolism ·Timothy J. Burton, Isla S. Mackenzie, Kottekkattu Balan, Brendan Koo, Nick Bird, Dmitry Soloviev, Elena Azizan, Franklin I. Aigbirhio, Mark Gurnell, Morris J. Brown
2011147
8
Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee
Clinical Endocrinology ·Onyebuchi Okosieme, Jackie Gilbert, Prakash Abraham, Kristien Boelaert, Colin Dayan, Mark Gurnell, Graham Leese, Christopher J. McCabe, Petros Perros, Vicki E. Smith, Graham R. Williams, Mark Vanderpump
2015136
9
PPARγ regulates the function of human dendritic cells primarily by altering lipid metabolism
Blood ·István Szatmári, Dániel Törőcsik, Maura Agostini, Tibor Nagy, Mark Gurnell, Endre Barta, Krishna Chatterjee, László Nagy
2007120
10
A role for helix 3 of the TRβ ligand‐binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone
The EMBO Journal ·Trevor N. Collingwood, Richard Wagner, Clare Matthews, Roderick Clifton‐Bligh, Mark Gurnell, Odelia Rajanayagam, Maura Agostini, Robert J. Fletterick, Paolo Beck‐Peccoz, Walter Reinhardt, Gerhard Binder, Michael B. Ranke, Ad R. Hermus, R.-D. Hesch, John H. Lazarus, P. G. Newrick, Vernon Parfitt, P R Raggatt, Francis de Zegher, Krishna Chatterjee
1998110
11
Elevated Plasma Adiponectin in Humans with Genetically Defective Insulin Receptors
The Journal of Clinical Endocrinology & Metabolism ·Robert K. Semple, Maria A. Soos, Jian’an Luan, Courtney Mitchell, J. C. Wilson, Mark Gurnell, Elaine Cochran, Phillip Görden, Krishna Chatterjee, Nicholas J. Wareham, Stephen O’Rahilly
2006105
12
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
The Lancet Respiratory Medicine ·Andrew Menzies‐Gow, Mark Gurnell, Liam G. Heaney, Jonathan Corren, Elisabeth H. Bel, Jorge Máspero, Timothy Harrison, David J. Jackson, David Price, Njira Lugogo, James L. Kreindler, Annie Burden, Alex De Giorgio-Miller, Kelly Padilla, Ubaldo J. Martin, Esther García Gil
2021101
13
An Adult Female With Resistance to Thyroid Hormone Mediated by Defective Thyroid Hormone Receptor α
The Journal of Clinical Endocrinology & Metabolism ·Carla Moran, Nadia Schoenmakers, Maura Agostini, Erik Schoenmakers, Amaka C Offiah, A. Kydd, G. Kahaly, Susan Mohr-Kahaly, Odelia Rajanayagam, Greta Lyons, Nicholas J. Wareham, David Halsall, Mehul Dattani, Stephen G. Hughes, Mark Gurnell, Soo‐Mi Park, Krishna Chatterjee
201398
14
Pregnancy, Primary Aldosteronism, and AdrenalCTNNB1Mutations
New England Journal of Medicine ·Ada Ee Der Teo, Sumedha Garg, Lalarukh Haris Shaikh, Junhua Zhou, Fiona E. Karet, Mark Gurnell, Lisa Happerfield, Alison Marker, Mariann Bienz, Elena Azizan, Morris J. Brown
201592
15
Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)α1 and TRα2: clinical, biochemical, and genetic analyses of three related patients
The Lancet Diabetes & Endocrinology ·Carla Moran, Maura Agostini, W. Edward Visser, Erik Schoenmakers, Nadia Schoenmakers, Amaka C Offiah, Ken Poole, Odelia Rajanayagam, Greta Lyons, David Halsall, Mark Gurnell, Dionisios Chrysis, Alexandra Efthymiadou, Charles Buchanan, Simon Aylwin, Krishna Chatterjee
201487
16
From molecule to market: steroid hormones and financial risk-taking
Philosophical Transactions of the Royal Society B Biological Sciences ·John Coates, Mark Gurnell, Zóltan Sarnyai
200978
17
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study
American Journal of Respiratory and Critical Care Medicine ·Carey Suehs, Andrew Menzies‐Gow, David Price, Eugene R. Bleecker, Giorgio Walter Canonica, Mark Gurnell, Arnaud Bourdin
202077
18
Functional implications of genetic variation in human PPARγ
Trends in Endocrinology and Metabolism ·Ellen H. Jeninga, Mark Gurnell, Eric Kalkhoven
200974
19
A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome
European Journal of Endocrinology ·Olympia Koulouri, Andrea Steuwe, Daniel Gillett, Andrew Hoole, Andrew Powlson, Neil Donnelly, N.G. Burnet, Nagui M. Antoun, Heok Cheow, Richard Mannion, John D. Pickard, Mark Gurnell
201570
20
The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance
Journal of Neurology Neurosurgery & Psychiatry ·Chin Lik Tan, Seyed Alireza Alavi, Stephanie E Baldeweg, Antonio Belli, Alan Carson, Claire Feeney, Anthony P. Goldstone, Richard Greenwood, David Menon, Helen Simpson, Andrew Toogood, Mark Gurnell, Peter J. Hutchinson
201766

About Mark Gurnell

Mark Gurnell is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Physiology and Pulmonary and Respiratory Medicine, having authored 161 papers that have together received 5.5k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (50 papers), Adrenal and Paraganglionic Tumors (26 papers), Thyroid Disorders and Treatments (24 papers), Hormonal Regulation and Hypertension (23 papers), Growth Hormone and Insulin-like Growth Factors (15 papers), Glioma Diagnosis and Treatment (14 papers), Peroxisome Proliferator-Activated Receptors (13 papers) and Electrolyte and hormonal disorders (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.1k citations), Physiology (1.0k citations), Biochemistry (250 citations), Molecular Biology (2.0k citations) and General Decision Sciences (46 citations). Mark Gurnell has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Krishna Chatterjee, Maura Agostini, Stephen O’Rahilly, John Coates, John W. R. Schwabe, Maria A. Soos, Inês Barroso, Vivion Crowley, G. Maslen and Alan J. Schafer. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Endocrinology, Pituitary, European Journal of Endocrinology and Medical Teacher.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard M. O’BrienBreakdown of academic impact, for papers by Marina BianchiBreakdown of academic impact, for papers by Robert K. SempleBreakdown of academic impact, for papers by Paul W. SandersBreakdown of academic impact, for papers by Ivan S. YuhannaBreakdown of academic impact, for papers by James ScottBreakdown of academic impact, for papers by Giovanni VitaleBreakdown of academic impact, for papers by Michael W. YehBreakdown of academic impact, for papers by David RubinsteinBreakdown of academic impact, for papers by Anthony N. Hollenberg